orbifloxacin has been researched along with enrofloxacin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gozalbes, R; Pineda-Lucena, A | 1 |
Heinen, E | 1 |
Abd El-Aty, AM; Kuroha, M; Nakamura, M; Regmi, NL; Shimoda, M | 1 |
Abd El-Aty, AM; Kubota, R; Regmi, NL; Shah, SS; Shimoda, M | 1 |
Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC | 1 |
Harada, K; Kataoka, Y; Shimizu, T; Takahashi, T | 1 |
Asai, T; Harada, K; Usui, M | 1 |
Greenbarg, EH; Secrest, SA | 1 |
Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
1 trial(s) available for orbifloxacin and enrofloxacin
Article | Year |
---|---|
Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Enrofloxacin; Fluoroquinolones; Injections, Intravenous; Male; Microsomes, Liver; Ofloxacin; Quinidine | 2007 |
9 other study(ies) available for orbifloxacin and enrofloxacin
Article | Year |
---|---|
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Dogs; Enrofloxacin; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Quinolones | 2002 |
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP1A1; Dogs; Drug Interactions; Enrofloxacin; Fluoroquinolones; Male; Microsomes, Liver; Norfloxacin; Ofloxacin | 2005 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2012 |
Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dogs; Enrofloxacin; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2012 |
Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.
Topics: Actinobacillus pleuropneumoniae; Anti-Bacterial Agents; Bacteriological Techniques; Ciprofloxacin; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Japan; Mannheimia haemolytica; Pasteurella multocida | 2014 |
What Is Your Diagnosis? Fungal pneumonia and aspergillosis.
Topics: Air Sacs; Animals; Anti-Infective Agents; Aspergillosis; Bird Diseases; Ciprofloxacin; Diagnosis, Differential; Eagles; Enrofloxacin; Female; Fluid Therapy; Fluoroquinolones; Iron-Dextran Complex; Radiography, Thoracic; Respiratory Tract Infections; Vitamin B Complex | 2016 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |